Patents by Inventor David Thomas Jonaitis

David Thomas Jonaitis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Ticagrelor Co-Crystal
    Publication number: 20160176912
    Abstract: The present invention relates to a novel co-crystal of the compound of formula (I): wherein the co-former molecule is acetyl salicylic acid, to processes for the preparation of the co-crystal, to the use of such a co-crystal in the manufacture of a medicament for use in the prevention of arterial thrombotic complications in patients with coronary artery, cerebrovascular or peripheral vascular disease and to methods of treating such diseases in the human or animal body by administering a therapeutically effective amount of a such a co-crystal.
    Type: Application
    Filed: June 29, 2015
    Publication date: June 23, 2016
    Inventors: Stephen David Cosgrove, David Thomas Jonaitis, Jonathan Charles Derrick Sutch
  • CRYSTALLINE NALOXOL-PEG CONJUGATE
    Publication number: 20150283257
    Abstract: Naloxol-polyethylene glycol conjugates of the formula: are provided in oxalate or phosphate salt forms including crystalline forms. Methods of preparing the salt forms and pharmaceutical compositions comprising the salt forms are also provided.
    Type: Application
    Filed: March 11, 2015
    Publication date: October 8, 2015
    Inventors: Bengt Aslund, Carl-Johan Aurell, Martin Hans Bohlin, Tesfai Sebhatu, Bo lngvar Ymen, Eric Thomas Healy, David Richard Jensen, David Thomas Jonaitis, Stephan Parent
  • Crystalline naloxol-PEG conjugate
    Patent number: 9149539
    Abstract: Naloxol-polyethylene glycol conjugates of the formula: are provided in oxalate or phosphate salt forms including crystalline forms. Methods of preparing the salt forms and pharmaceutical compositions comprising the salt forms are also provided.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: October 6, 2015
    Assignees: ASTRAZENECA AB, NEKTAR THERAPEUTICS
    Inventors: Bengt Aslund, Carl-Johan Aurell, Martin Hans Bohlin, Tesfai Sebhatu, Bo Ingvar Ymen, Eric Thomas Healy, David Richard Jensen, David Thomas Jonaitis, Stephan Parent
  • Ticagrelor co-crystal
    Patent number: 9101642
    Abstract: The present invention relates to a novel co-crystal of the compound of formula (I): wherein the co-former molecule is acetyl salicylic acid, to processes for the preparation of the co-crystal, to pharmaceutical compositions containing the co-crystal, to the use of such a co-crystal in the manufacture of a medicament for use in the prevention of arterial thrombotic complications in patients with coronary artery, cerebrovascular or peripheral vascular disease and to methods of treating such diseases in the human or animal body by administering a therapeutically effective amount of a such a co-crystal.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: August 11, 2015
    Assignee: AstraZeneca AB
    Inventors: Stephen David Cosgrove, David Thomas Jonaitis, Jonathan Charles Derrick Sutch
  • Crystalline naloxol-peg conjugate
    Patent number: 9012469
    Abstract: Naloxol-polyethlyene glycol conjugates of the formula: are provided in oxalate or phosphate salt forms including crystalline forms. Methods of preparing the salt forms and pharmaceutical compositions comprising the salt forms are also provided.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: April 21, 2015
    Assignees: AstraZeneca AB, Nektar Therapeutics
    Inventors: Bengt Leonard Åslund, Carl-Johan Aurell, Martin Hans Bohlin, Eric Thomas Healy, David Richard Jensen, David Thomas Jonaitis, Stephan Parent, Tesfai Sebhatu, Bo Ingvar Ymén
  • CRYSTALLINE NALOXOL-PEG CONJUGATE
    Publication number: 20150038524
    Abstract: Naloxol-polyethylene glycol conjugates of the formula: are provided in oxalate or phosphate salt forms including crystalline forms. Methods of preparing the salt forms and pharmaceutical compositions comprising the salt forms are also provided.
    Type: Application
    Filed: September 29, 2011
    Publication date: February 5, 2015
    Applicant: ASTRAZENECA INTELLECTUAL PROPERTY
    Inventors: Bengt Leonard Aslund, Carl-Johan Aurell, Martin Hans Bohlin, David Richard Jensen, David Thomas Jonaitis, Eric Thomas Healy, Bo Ingvar Ymén, Stephan Parent, Tesfai Sebhatu
  • Novel Ticagrelor Co-Crystal
    Publication number: 20140148403
    Abstract: The present invention relates to a novel co-crystal of the compound of formula (I): wherein the co-former molecule is acetyl salicylic acid, to processes for the preparation of the co-crystal, to pharmaceutical compositions containing the co-crystal, to the use of such a co-crystal in the manufacture of a medicament for use in the prevention of arterial thrombotic complications in patients with coronary artery, cerebrovascular or peripheral vascular disease and to methods of treating such diseases in the human or animal body by administering a therapeutically effective amount of a such a co-crystal.
    Type: Application
    Filed: May 31, 2012
    Publication date: May 29, 2014
    Applicant: AstraZeneca UK Limited
    Inventors: Stephen David Cosgrove, David Thomas Jonaitis, Jonathan Charles Derrick Sutch